Insta
China Approves Clinical Trials For 16 COVID-19 Vaccine Candidates; Six Already In The Third Stage
Wuhan
In a big push towards the development of vaccines to tackle the continuing menace of COVID-19, China has approved clinical trials for 16 indigenous vaccine candidates, six of which are already in the third stage, reports Economic Times.
The latest set of vaccine candidates are said to based on recombinant protein, adenovirus vector, nucleic acid and attenuates influenza-viruses technologies as per the data from National Medical Products Administration.
Meanwhile, it should be noted that the authorities in China have already accorded conditional approval to two inactivated COVID-19 vaccines developed by state-owned firms Sinopharm and Sinovac Biotech.
As per the Chinese state-run media Xinhua, as of 9 February, China had completed vaccinating 40.52 million people in the key groups. The nation has so far reported 4,833 deaths and 1,00,727 confirmed cases.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
